Histamine, histamine H
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
27
10
2018
revised:
20
12
2018
accepted:
11
02
2019
pubmed:
26
2
2019
medline:
22
6
2021
entrez:
26
2
2019
Statut:
ppublish
Résumé
Alcohol use disorder is associated with several mental, physical, and social problems. Its treatment is difficult and often requires a combination of pharmacological and behavioural therapy. The brain histaminergic system, one of the wake-active systems that controls whole-brain activity, operates through three neuronal GPCRs. The histamine H
Identifiants
pubmed: 30801695
doi: 10.1111/bph.14634
pmc: PMC7012945
doi:
Substances chimiques
Receptors, Histamine H3
0
Histamine
820484N8I3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
634-641Subventions
Organisme : Suomen Akatemia
Pays : International
Organisme : Finska Läkaresällskapet
Pays : International
Organisme : Finnish Fund for Alcohol Research
Pays : International
Organisme : Sigrid Juselius Foundation
Pays : International
Informations de copyright
© 2019 The British Pharmacological Society.
Références
Neuron. 2017 Dec 20;96(6):1223-1238
pubmed: 29268093
FASEB J. 2001 Apr;15(6):1074-6
pubmed: 11292672
Alcohol Clin Exp Res. 2000 Jul;24(7):1120-4
pubmed: 10924018
Neuropharmacology. 2016 Jul;106:91-101
pubmed: 26169221
Neuroscience. 2005;132(1):137-49
pubmed: 15780473
Int J Neuropsychopharmacol. 2013 Jul;16(6):1231-9
pubmed: 23217964
Neuroscience. 2002;114(1):173-93
pubmed: 12207964
Mol Pharmacol. 2001 Jan;59(1):1-8
pubmed: 11125017
Pharmacol Rev. 2015 Oct;67(4):872-1004
pubmed: 26403687
Neuropharmacology. 2004 Feb;46(2):243-53
pubmed: 14680762
Exp Neurol. 2000 May;163(1):20-30
pubmed: 10785440
J Pharmacol Exp Ther. 2016 May;357(2):264-72
pubmed: 26945087
BMC Neurosci. 2003 Sep 24;4:24
pubmed: 14505495
J Comp Neurol. 1988 Jul 15;273(3):283-300
pubmed: 3062046
Curr Opin Neurobiol. 2004 Jun;14(3):370-8
pubmed: 15194118
J Neurosci. 2002 Mar 15;22(6):2074-82
pubmed: 11896147
Inflamm Res. 2005 Apr;54 Suppl 1:S23-4
pubmed: 15928819
Nat Rev Neurosci. 2013 Jul;14(7):472-87
pubmed: 23783198
Brain Res. 1984 Mar 12;295(1):13-25
pubmed: 6713171
Neuroscience. 1989;28(3):585-610
pubmed: 2710333
Eur J Pharmacol. 1998 Jul 24;353(2-3):149-58
pubmed: 9726645
Front Syst Neurosci. 2012 May 04;6:33
pubmed: 22586376
Br J Pharmacol. 2020 Feb;177(3):634-641
pubmed: 30801695
J Neurosci. 2004 Oct 6;24(40):8704-10
pubmed: 15470136
Behav Neurosci. 2005 Feb;119(1):213-23
pubmed: 15727526
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Behav Brain Res. 2013 Jan 1;236(1):157-165
pubmed: 22974550
J Stud Alcohol Drugs. 2013 Nov;74(6):894-901
pubmed: 24172116
Alcohol Alcohol. 2016 Sep;51(5):535-40
pubmed: 27307055
Hum Mol Genet. 2005 Jul 1;14(13):1709-25
pubmed: 15888489
Alcohol Clin Exp Res. 2005 Oct;29(10):1821-8
pubmed: 16269911
Neuroreport. 2000 Mar 20;11(4):755-9
pubmed: 10757514
Nat Genet. 1996 Sep;14(1):98-101
pubmed: 8782828
Pharmacol Biochem Behav. 2000 Dec;67(4):693-9
pubmed: 11166059
J Neurochem. 2003 Feb;84(4):698-704
pubmed: 12562514
Neurobiol Dis. 2001 Aug;8(4):707-16
pubmed: 11493035
Br J Pharmacol. 2017 Dec;174 Suppl 1:S130-S159
pubmed: 29055038
Neuroscience. 1990;34(1):127-32
pubmed: 2325846
J Comp Neurol. 1991 Sep 1;311(1):45-64
pubmed: 1719044
Eur J Neurosci. 2000 Nov;12(11):3823-32
pubmed: 11069577
Neuropsychopharmacology. 2011 Sep;36(10):2030-40
pubmed: 21654737
J Neural Transm Gen Sect. 1993;93(1):1-10
pubmed: 8396945
J Pharmacol Exp Ther. 2010 Jan;332(1):164-72
pubmed: 19815811
Physiol Behav. 2015 Nov 1;151:189-97
pubmed: 26169446
Neuropharmacology. 2016 Jul;106:156-63
pubmed: 26107118
Pharmacol Rev. 2015 Jul;67(3):601-55
pubmed: 26084539
Nature. 1996 Oct 31;383(6603):819-23
pubmed: 8893006
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2572-6
pubmed: 6371818
Alcohol Clin Exp Res. 2008 Jun;32(6):1040-8
pubmed: 18422836
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16963-8
pubmed: 24082084
Psychopharmacology (Berl). 2000 Apr;149(3):217-24
pubmed: 10823401
Psychopharmacology (Berl). 2013 Jul;228(1):85-95
pubmed: 23474889
J Pharmacol Exp Ther. 2009 May;329(2):625-33
pubmed: 19225162
Br J Pharmacol. 2017 Dec;174 Suppl 1:S17-S129
pubmed: 29055040
Cell Rep. 2014 Nov 6;9(3):930-43
pubmed: 25437550
FASEB J. 2011 Dec;25(12):4338-47
pubmed: 21885652
Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82
pubmed: 14574227
Trends Neurosci. 2014 Mar;37(3):159-68
pubmed: 24486025
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Alcohol. 2000 Nov;22(3):165-71
pubmed: 11163124
Eur J Pharmacol. 2015 Jan 5;746:1-5
pubmed: 25445043
Alcohol. 1998 May;15(4):281-9
pubmed: 9590512
Eur J Neurosci. 2002 Apr;15(7):1125-38
pubmed: 11982624
Life Sci. 1980 Mar 3;26(9):679-88
pubmed: 6767889
Nat Rev Neurosci. 2003 Feb;4(2):121-30
pubmed: 12563283
Psychopharmacology (Berl). 2010 Jan;208(1):75-86
pubmed: 19911169
Am J Drug Alcohol Abuse. 2014 Mar;40(2):103-10
pubmed: 24456403